PRKCA and breast cancer: Patients with PKCα-positive breast tumors exhibited increased mortality relative to those that are PKCα-negative44, and breast cancer cell lines with high levels of PKCα (e.g., MDA-MB-231) proliferate faster than those with low PKCα levels (e.g., T47D)45.